Gold soars to record high over $3,900/oz amid yen slump, US rate cut bets
On Friday, Berenberg reinstated coverage on Hiscox Ltd. (LON:HSX:LN) (OTC: HCXLF), issuing a Buy rating with a price target of GBP14.50. The firm’s analyst highlighted the potential of the company’s Retail business, which has recently gained prominence. With a market capitalization of $5.86 billion and trading near its 52-week high, Hiscox has shown strong momentum, according to InvestingPro data. This follows Hiscox’s first-ever capital markets day held in May 2025, where the company outlined its growth strategy for the Retail division.
The analyst at Berenberg expressed optimism about the future growth of Hiscox’s Retail business, noting that it is poised to become a more significant contributor to the company’s overall performance. InvestingPro data shows the company achieved 2.94% revenue growth in the last twelve months, with a "GREAT" overall financial health score. With Hiscox holding small retail market shares in its primary markets, the firm sees substantial opportunities for the company to expand more rapidly than the broader market.
Furthermore, the Retail sector is characterized by lower volatility compared to Hiscox’s big-ticket lines of business. This stability, combined with the planned cost savings of approximately $0.2 billion, is expected to bolster the group’s profitability. Berenberg anticipates that Hiscox could sustain profitability in the mid-teens percentage range through various market cycles.
In terms of valuation, Hiscox is currently trading at 1.55 times price-to-book (P/B) ratio and a P/E ratio of 9.49x based on InvestingPro data, which indicates the stock is currently fairly valued according to InvestingPro’s Fair Value model. According to the analyst, the current share price does not fully reflect the company’s growth prospects and potential for sustained profitability. For deeper insights into Hiscox’s valuation and growth potential, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.
In other recent news, Hiscox has announced plans to achieve $200 million in efficiency gains starting from 2028. This initiative is part of an operational overhaul aimed at reducing costs and leveraging scale across its global insurance business. The company is focusing on expanding its margins in the small commercial and high-net-worth individual lines, which are seen as having significant growth potential. Hiscox is also increasing investments in distribution and product development to support these efforts.
Additionally, Citi analysts have raised their price target for Hiscox to GBP13.30, up from GBP12.24, while maintaining a Neutral rating on the stock. This update follows Hiscox’s recent core results, which were considered encouraging despite challenges like an anticipated rise in the tax rate and wildfire losses. The company has also re-based its dividend and executed a share buyback slightly above expectations. Citi analysts note the potential for growth in the US Direct market, despite ongoing challenges in Partnerships, with expectations of momentum building into 2025. Hiscox’s solvency position is seen as providing opportunities to capitalize on prospects in 2025, despite adjustments to earnings forecasts due to wildfire losses.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.